Olaparix (Olaparib 150mg / 50mg) Rx
Olaparix (Olaparib 150mg / 50mg) Rx $530.00 $1,010.00Price range: $530.00 through $1,010.00
Back to products
Description

Bacillus Calmette Guerin-BCG, (Onco-BCG) works for treating bladder cancer of flat (also called urothelial cell carcinoma). Bacillus Calmette Guerin-BCG is a doctor prescription (Bacillus Calmette Guerin-BCG) medicine.

Mylan Pharmaceuticals Pvt. Ltd. of India mfg Onco-BCG.

Your doctor or nurse will give you this medicine. Kindly do not self administer.

 

Suggestion:

Genuine medicine is important for treatment. So, always try to source genuine medicines from authentic sources and check the quality of medicines.

Side Effect:

The most common side effects of Bacillus Calmette Guerin are:

Increased urination, painful urination, fever or flu symptoms. Tell your doctor or pharmacist right away if any of these side effects persist or worsen.

Remember that your doctor has prescribed this medication because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor right away if you have any serious side effects, including: fever, chills, aches, weakness, flu-like symptoms, cough or trouble breathing, pain or burning when you urinate;a weak stream of urine, trouble emptying your bladder, blood in your urine, dark urine, vomiting, upper stomach pain, jaundice (yellowing of your skin or eyes) or signs of a penis infection–burning, itching, odor, discharge, pain, tenderness, redness or swelling of the genital or rectal area, fever, not feeling well.

Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice.

This is not a complete list of possible side effects. Contact your doctor or pharmacist if you have any other side effects not listed above.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Onco-BCG (Bacillus Calmette Guerin 40mg) Rx”

Your email address will not be published. Required fields are marked *